KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Non-Current Deferred Tax Liability (2016 - 2019)

Historic Non-Current Deferred Tax Liability for Arbutus Biopharma (ABUS) over the last 5 years, with Q2 2019 value amounting to $12.7 million.

  • Arbutus Biopharma's Non-Current Deferred Tax Liability fell 2527.3% to $12.7 million in Q2 2019 from the same period last year, while for Jun 2019 it was $12.7 million, marking a year-over-year decrease of 2527.3%. This contributed to the annual value of $12.7 million for FY2018, which is 2527.3% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Non-Current Deferred Tax Liability of $12.7 million as of Q2 2019, which was down 2527.3% from $12.7 million recorded in Q1 2019.
  • In the past 5 years, Arbutus Biopharma's Non-Current Deferred Tax Liability registered a high of $156.0 million during Q2 2015, and its lowest value of $12.7 million during Q3 2018.
  • Over the past 5 years, Arbutus Biopharma's median Non-Current Deferred Tax Liability value was $41.3 million (recorded in 2016), while the average stood at $65.3 million.
  • The largest annual percentage gain for Arbutus Biopharma's Non-Current Deferred Tax Liability in the last 5 years was 612.13% (2016), contrasted with its biggest fall of 7180.03% (2016).
  • Quarter analysis of 5 years shows Arbutus Biopharma's Non-Current Deferred Tax Liability stood at $146.3 million in 2015, then crashed by 71.8% to $41.3 million in 2016, then crashed by 58.94% to $16.9 million in 2017, then fell by 25.27% to $12.7 million in 2018, then changed by 0.0% to $12.7 million in 2019.
  • Its last three reported values are $12.7 million in Q2 2019, $12.7 million for Q1 2019, and $12.7 million during Q4 2018.